Analytical Data
-
基因名
CTNNA3
- Application
-
别名
4930429L08Rik; 4933408A16; Alpha catenin like protein; Alpha T catenin; Alpha T-catenin; Cadherin associated protein ; Cadherin-associated protein; Catenin alpha 3; Catenin alpha-3; Catna3; CTNA3_HUMAN; CTNNA3
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UI47
-
表达区间
1-376aa
-
氨基酸序列
MSAETPITLNIDPQDLQVQTFTVEKLLEPLIIQVTTLVNCPQNPSSRKKGRSKRASVLLASVEEATWNLLDKGEKIAQEATVLKDELTASLEKVRKESEALKVSAERFTDDPCFLPKREAVVQAARALLAAVTRLLILADMIDVMCLLQHVSAFQRTFESLKNVANKSDLQKTYQKLGKELENLDYLAFKRQQDLKSPNQRDEIAGARASLKENSPLLHSICSACLEHSDVASLKASKDTVCEEIQNALNVISNASQGIQNMTTPPEPQAATLGSALDELENLIVLNPLTVTEEEIRPSLEKRLEAIISGAALLADSSCTRDLHRERIIAECNAIRQALQDLLSEYMNNLCNQKSDLGLTGVKIKLLEECIIFWSL
-
分子量
67.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CTNNA3, or Catenin Alpha 3, is a member of the catenin family, which plays a crucial role in cell adhesion, signaling, and cytoskeletal organization. It is predominantly expressed in the brain and has been implicated in various neurological processes. Research has indicated that CTNNA3 is involved in the regulation of synaptic plasticity and neuronal connectivity, making it a potential player in the pathogenesis of neurodevelopmental and neuropsychiatric disorders, including autism spectrum disorders and schizophrenia. Furthermore, mutations and dysregulation of CTNNA3 have been associated with increased susceptibility to these conditions. Given its critical role in neuronal function, CTNNA3 has become a target for studying the molecular mechanisms underlying these disorders. The development of recombinant CTNNA3 proteins is pivotal for elucidating its biological functions and interactions in cellular pathways. This includes investigating its binding partners, participation in cellular adhesion processes, and impact on cell signaling pathways. Understanding the structure and function of CTNNA3 through recombinant protein studies may also lead to novel therapeutic strategies for neurological conditions linked to its aberrant expression or function. As such, the research of CTNNA3 recombinant proteins is not only essential for advancing our fundamental knowledge of synaptic biology but also for contributing to potential clinical implications in neurodevelopmental and neuropsychiatric conditions.
